These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7533653)

  • 1. Patients with ultrasonic coarse-nodular cirrhosis who are anti-hepatitis C virus-positive are at high risk for hepatocellular carcinoma.
    Tarao K; Hoshino H; Shimizu A; Ohkawa S; Harada M; Nakamura Y; Ito Y; Tamai S; Okamoto N
    Cancer; 1995 Mar; 75(6):1255-62. PubMed ID: 7533653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients.
    Tarao K; Ohkawa S; Shimizu A; Harada M; Nakamura Y; Ito Y; Tamai S; Hoshino H; Inoue T; Kanisawa M
    Cancer; 1994 Feb; 73(4):1149-54. PubMed ID: 7508816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.
    Benvegnù L; Noventa F; Bernardinello E; Pontisso P; Gatta A; Alberti A
    Gut; 2001 Jan; 48(1):110-5. PubMed ID: 11115831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men.
    Tarao K; Ohkawa S; Shimizu A; Harada M; Nakamura Y; Ito Y; Tamai S; Hoshino H; Okamoto N; Iimori K
    Cancer; 1993 Jul; 72(2):369-74. PubMed ID: 7686441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of increased DNA synthesis activity of hepatocytes in multicentric hepatocarcinogenesis in residual liver of hepatectomized cirrhotic patients with hepatocellular carcinoma.
    Tarao K; Hoshino H; Shimizu A; Ohkawa S; Nakamura Y; Harada M; Ito Y; Tamai S; Akaike M; Sugimasa Y
    Jpn J Cancer Res; 1994 Oct; 85(10):1040-4. PubMed ID: 7961106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coarse nodular US pattern in hepatic cirrhosis: risk for hepatocellular carcinoma.
    Caturelli E; Castellano L; Fusilli S; Palmentieri B; Niro GA; del Vecchio-Blanco C; Andriulli A; de Sio I
    Radiology; 2003 Mar; 226(3):691-7. PubMed ID: 12601208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis.
    Tarao K; Shimizu A; Ohkawa S; Harada M; Ito Y; Tamai S; Kuni Y; Okamoto N; Inoue T; Kanisawa M
    Gastroenterology; 1992 Aug; 103(2):595-600. PubMed ID: 1321773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns.
    Soresi M; Terranova A; Licata A; Serruto A; Montalto G; Brancatelli G; Giannitrapani L
    Biomed Res Int; 2017; 2017():4932759. PubMed ID: 28638828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis.
    Tarao K; Rino Y; Ohkawa S; Tamai S; Miyakawa K; Takakura H; Endo O; Yoshitsugu M; Watanabe N; Matsuzaki S
    Cancer; 2002 Mar; 94(6):1787-95. PubMed ID: 11920542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA synthesis activities of hepatocytes from noncancerous cirrhotic tissue and of hepatocellular carcinoma (HCC) cells from cancerous tissue can predict the survival of hepatectomized patients with HCC.
    Tarao K; Ohkawa S; Shimizu A; Harada M; Nakamura Y; Okamoto N; Ito Y; Tamai S; Iimori K; Sugimasa Y
    Cancer; 1993 Jun; 71(12):3859-63. PubMed ID: 8389652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased DNA synthetic potency of hepatocytes in cirrhotic patients may indicate a super-high risk for hepatocellular carcinoma.
    Tarao K; Shimizu A; Harada M; Ohkawa S; Tamai S; Ito Y; Kuni Y; Takemiya S; Okamoto T
    Jpn J Med; 1990; 29(4):373-8. PubMed ID: 2177116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis.
    Tarao K; Rino Y; Ohkawa S; Shimizu A; Tamai S; Miyakawa K; Aoki H; Imada T; Shindo K; Okamoto N; Totsuka S
    Cancer; 1999 Aug; 86(4):589-95. PubMed ID: 10440686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
    Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
    Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection.
    Shibata M; Morizane T; Uchida T; Yamagami T; Onozuka Y; Nakano M; Mitamura K; Ueno Y
    Lancet; 1998 Jun; 351(9118):1773-7. PubMed ID: 9635950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
    Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
    J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irregularity of parenchymal echo patterns of liver analyzed with a neural network and risk of hepatocellular carcinoma in liver cirrhosis.
    Fukuda H; Ebara M; Kobayashi A; Sugiura N; Yoshikawa M; Saisho H; Kato K; Kondo F; Yahagi T
    Oncology; 2002; 63(3):270-9. PubMed ID: 12381907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.